138 related articles for article (PubMed ID: 2684682)
1. A comparison between regimens containing chemotherapy alone (busulfan and cyclophosphamide) and chemotherapy (V. RAPID) plus total body irradiation on marrow engraftment following allogeneic bone marrow transplantation.
Reynolds M; McCann SR
Eur J Haematol; 1989 Oct; 43(4):314-20. PubMed ID: 2684682
[TBL] [Abstract][Full Text] [Related]
2. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Domenech J; Linassier C; Gihana E; Dayan A; Truglio D; Bout M; Petitdidier C; Delain M; Petit A; Brémond JL
Blood; 1995 Jun; 85(11):3320-7. PubMed ID: 7756665
[TBL] [Abstract][Full Text] [Related]
3. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
4. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
5. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
Dusenbery KE; Daniels KA; McClure JS; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Kersey JH; Woods WG
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):119-28. PubMed ID: 7995742
[TBL] [Abstract][Full Text] [Related]
7. The development of busulfan/cyclophosphamide preparative regimens.
Santos GW
Semin Oncol; 1993 Aug; 20(4 Suppl 4):12-6; quiz 17. PubMed ID: 8342070
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
10. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
11. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E
Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers.
Kirkland MA; Spencer A; Davidson RJ; McDonald C; Goldman JM
Blood; 1996 May; 87(9):3963-9. PubMed ID: 8611728
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of heme and IL-1 on hematopoietic stromal regeneration after radiation.
Lutton JD; Chertkov JL; Jiang S; Kappas A; Levere RD; Abraham NG
Am J Hematol; 1993 Nov; 44(3):172-8. PubMed ID: 8213766
[TBL] [Abstract][Full Text] [Related]
14. Effects of low dose rate irradiation on human marrow hematopoietic and microenvironmental cells: sparing effect upon survival of stromal and leukemic cells.
Laver J; Kwon JH; Castro-Malaspina H
Bone Marrow Transplant; 1987 Oct; 2(3):271-8. PubMed ID: 3332175
[TBL] [Abstract][Full Text] [Related]
15. Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan.
Mauch P; Down JD; Warhol M; Hellman S
Transplantation; 1988 Aug; 46(2):205-10. PubMed ID: 3043777
[TBL] [Abstract][Full Text] [Related]
16. Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
Van der Jagt RH; Appelbaum FR; Petersen FB; Bigelow CL; Fisher LD; Schoch GH; Buckner CD; Sanders JE; Storb R; Sullivan KM
Bone Marrow Transplant; 1991 Sep; 8(3):211-5. PubMed ID: 1958901
[TBL] [Abstract][Full Text] [Related]
17. Early recovery of host-derived hematopoiesis in marrow transplant recipients conditioned with high-dose busulfan and cyclophosphamide.
Yamaguchi M; Nakao S; Ueda M; Takamatsu H; Tamaru Y; Shiobara S; Masauji N; Matsue K; Matsuda T
Bone Marrow Transplant; 1995 May; 15(5):787-9. PubMed ID: 7670408
[TBL] [Abstract][Full Text] [Related]
18. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
19. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
20. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.
Galotto M; Berisso G; Delfino L; Podesta M; Ottaggio L; Dallorso S; Dufour C; Ferrara GB; Abbondandolo A; Dini G; Bacigalupo A; Cancedda R; Quarto R
Exp Hematol; 1999 Sep; 27(9):1460-6. PubMed ID: 10480437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
